experimental group :Apatinib

3 trials

Sponsors

Zhejiang Cancer Hospital, Sun Yat-Sen University Cancer Center

Conditions

Malignant tumor of thymusUndifferentiated thyroid carcinomaglioblastoma

Phase 4

An prospective, single center, open, stage II clinical trail of Apatinib for treatment of locally advanced or metastatic thyroid undifferentiated thyroid cancer

RecruitingChiCTR-OPC-17012676

Zhejiang Cancer HospitalUndifferentiated thyroid carcinoma

Start: 2017-09-18Updated: 2017-10-02

A phase II, multicenter study of apatinib in progressive/recurrent glioblastoma

RecruitingChiCTR-OPC-17013350

Sun Yat-Sen University Cancer Centerglioblastoma

Start: 2017-12-01Updated: 2017-11-20

Unknown Phase

Phase II trial of Apatinib in patients with recurrence or metastasis of malignant tumors of the thymus after failure of platinum chemotherapy

RecruitingChiCTR-ONC-17013108

Zhejiang Cancer HospitalMalignant tumor of thymus

Start: 2017-10-30Updated: 2017-11-06